Trevor James
Vaccinations can cause fever in infants, which can be distressing for both the child and the parents. Paracetamol, also known as acetaminophen, is often used as an antipyretic to reduce fever and pain. While it is effective in reducing fever, there are concerns that giving paracetamol before or after immunisation may reduce the immune response to the vaccine, making it less effective. This has prompted some countries to advise against its routine use for fever prophylaxis in infants. This topic explores the evidence and recommendations regarding the use of prophylactic paracetamol to prevent fever after vaccination in infants and its potential impact on vaccine efficacy.
| Characteristics | Values |
|---|---|
| Use case | Prevent fever in infants after vaccination |
| Drug | Prophylactic paracetamol |
| Effectiveness | May reduce fever and improve infant comfort |
| Side effects | May reduce antibody responses to some vaccines |
| Dosage | 10 mg/kg to 15 mg/kg |
| Administration time | At vaccination or as soon as possible afterwards |
| Number of doses | 3 doses |
| Time between doses | 4 to 6 hours |
| Dose amount | 2.5ml (60mg) |
| Administration method | Syringe or spoon |
| Age | Up to 18 years |
| Country recommendations | Varies; not recommended in Canada and New Zealand; recommended in the UK and Ireland for MenB vaccine |
Explore related products
What You'll Learn
- Paracetamol is the most common medication used to treat fever in infants
- Paracetamol may blunt the immune response to vaccines
- Some countries no longer recommend routine prophylaxis
- Paracetamol can be used to prevent fever after MenB vaccination
- Prophylactic antipyretics affect immune responses to vaccines
Paracetamol is the most common medication used to treat fever in infants
Paracetamol, also known as acetaminophen, is the most common medication used to treat fever in infants. It is often used to treat mild to moderate pain and fever in children. It is available in the form of drops, liquids, chewable tablets, and suppositories for children older than one month. Ibuprofen is another common medication used for the same purpose and is approved for children older than three months.
There is a debate about the benefits and harms of fever-reducing interventions, with some experts arguing that reducing fever may interfere with its beneficial role during illness. For instance, one report suggests that treatment with antipyretic drugs could increase mortality in severe infections, prolong viral shedding, and impair antibody response to viral infection. However, a Cochrane review found insufficient evidence to support this view.
Some studies have found significant benefits of prophylactic paracetamol in fever prevention and reducing fussiness in children after vaccination. However, other studies have raised concerns that paracetamol use following immunization could lead to reduced immune responses and lower antibody responses to some vaccines. As a result, routine prophylaxis is no longer recommended in some countries, such as Canada and New Zealand.
Given the uncertainties, more research is needed to evaluate the efficacy and safety of prophylactic paracetamol in preventing fever following vaccination in children. While it may be useful in managing pain and fever, the potential impact on immune responses needs to be carefully considered.
Hepatitis Vaccine History: Children in the 1980s
You may want to see also
Explore related products
Paracetamol may blunt the immune response to vaccines
Paracetamol, also known as acetaminophen, is the most common antipyretic medication used in children for the treatment of post-immunization fever and pain. However, there are concerns that its use may lead to reduced immune responses.
Two randomized, non-blinded, controlled, open-label trials were conducted in 2006 and 2007 to assess the effect of prophylactic acetaminophen on fever and immunogenicity in children receiving routine primary and booster immunizations. The study participants, healthy infants aged 9 to 16 weeks, were immunized with 10-valent pneumococcal, non-typeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) and hexavalent diphtheria-tetanus-3-component. The results showed that antibody geometric mean concentrations were significantly lower in the acetaminophen group after primary vaccination for all 10 pneumococcal vaccine serotypes and for Haemophilus, pertussis, diphtheria, and tetanus vaccines. Even after boosting, lower antibody geometric mean titers persisted in the acetaminophen group for tetanus, Haemophilus, and 9 of 10 pneumococcal serotypes.
These findings suggest that acetaminophen use after immunization may reduce the immune response to vaccine components, despite reducing the risk of febrile reactions. As a result, some countries, such as Canada and New Zealand, no longer recommend routine prophylaxis with acetaminophen for fever prevention in vaccinated children.
While treating pain and discomfort in children is recommended, the evidence regarding the benefits of treating fever with paracetamol is inconclusive. The potential reduction in immune response due to paracetamol use must be carefully considered against the benefits of fever reduction and behavioral changes in infants.
Vaccine Arm Swelling: To Swing or Not to Swing?
You may want to see also
Explore related products
Some countries no longer recommend routine prophylaxis
Some countries, including Canada and New Zealand, no longer recommend routine prophylaxis. This decision was made after a report suggested that there may be a reduced immune response to vaccines in children given paracetamol for fever prophylaxis. A non-Cochrane systematic review affirmed this, finding a reduction in antibody responses to some vaccine antigens with prophylactic use of antipyretics. However, the review also suggested that such a reduction in immune responses might not be clinically significant.
The World Health Organization (WHO) recommends at least 10 vaccines for routine immunisation in children. Certain types of vaccines, such as the whole-cell pertussis vaccine, have a higher risk of causing fever. While treating pain and discomfort in children is recommended, evidence regarding the benefits of treating fever with paracetamol is inconclusive.
Two studies evaluated the safety of prophylactic paracetamol in 2009, and both found that antibody responses to several antigens were significantly reduced. One study found that febrile reactions were significantly reduced, but since antibody responses were significantly lowered, prophylactic paracetamol at the time of vaccination should not be routinely recommended.
Paracetamol is the most common antipyretic medication used in children for prophylaxis and treatment of post-immunization fever and pain. It is often given to infants after the MenB vaccine, which is usually administered at a baby's first and second immunisation appointments at 8 and 12 weeks of age. Paracetamol is advised following the MenB vaccine as more than half of infants will develop a temperature without it. However, by 12 months of age, a baby's risk of fever after the MenB vaccine is the same as with other vaccines, so paracetamol is not routinely needed.
Eggland's Best: Salmonella-Free Chickens?
You may want to see also
Explore related products
Paracetamol can be used to prevent fever after MenB vaccination
Fever is a common occurrence after any vaccination, but it is more likely to occur when the MenB vaccine is given alongside other routine vaccines at 8 and 12 weeks. Without paracetamol, over half of infants will develop a fever. However, giving paracetamol soon after vaccination can reduce the risk of fever, with fewer than 1 in 5 children developing a fever, and nearly all of these being mild.
Paracetamol is advised for babies following the MenB vaccination, which is usually given at the baby's first and second immunisation appointments at 8 and 12 weeks of age. A total of three doses of 2.5ml (60mg) of paracetamol are recommended following the MenB vaccination. The first dose should be given at the time of vaccination or as soon as possible afterwards. The second dose should be given around 4 to 6 hours later, and the third dose 4 to 6 hours after that.
The use of paracetamol in this context is supported by a study by Prymula and colleagues in 2009, which found that prophylactic acetaminophen (paracetamol) significantly reduced fever following routine childhood immunisation. However, it is important to note that this study also found that paracetamol blunted the immune response to several vaccine antigens, with infants in the paracetamol group exhibiting significantly lower antibody levels than those in the control group.
Due to these findings, routine prophylaxis is no longer recommended in some countries, such as Canada and New Zealand. However, in the UK and Ireland, guidance was issued in 2015 recommending the prophylactic administration of paracetamol to infants around the time of MenB immunisation and post-immunisation.
It is worth noting that the World Health Organization (WHO) has advised against the administration of prophylactic oral analgesics due to a lack of evidence of effectiveness and/or the potential for affecting vaccine response. The American Academy of Pediatrics has also stated that more studies are needed to explore the clinical impact of antipyretics on vaccination.
The Immune System: Our Body's Defense Mechanism
You may want to see also
Explore related products
Prophylactic antipyretics affect immune responses to vaccines
Fever and discomfort after vaccination can negatively influence parents' perception of the safety of routine childhood immunizations. Paracetamol, also known as acetaminophen, is the most common antipyretic medication used in children for prophylaxis and treatment of post-immunization fever and pain. While treating pain and discomfort in children is recommended, evidence regarding the benefits of treating fever with paracetamol is not conclusive.
Some studies have found that prophylactic administration of antipyretics at the time of immunization may decrease side effects, but it can also reduce immune responses. A systematic review of five randomized controlled trials including 2775 children found that the prophylactic administration of paracetamol decreased the immune response to certain pneumococcal serotypes in all included studies. The effect was more evident following primary vaccination and with immediate administration of paracetamol. Another study found that prophylactic paracetamol may interfere with immune responses to pneumococcal antigens, and ibuprofen may reduce responses to pertussis and tetanus antigens.
The World Health Organization (WHO) advises against the administration of prophylactic oral analgesics due to a lack of evidence of effectiveness and/or the potential for affecting vaccine response. The American Academy of Pediatrics in 2010 stated that more studies are needed to explore the clinical impact of antipyretics on vaccination and recommended discussing the risks and benefits of prophylactic or therapeutic antipyretics with parents. Given the uncertainties, further research is needed to inform clinical and policy decisions on the use of paracetamol as a prophylactic to prevent fever following vaccination in children.
Alabama's Religious Exemption for Vaccines: What's the Verdict?
You may want to see also
Frequently asked questions
Yes, prophylactic paracetamol can prevent fever after vaccination in infants. However, it is not routinely recommended as it may reduce the effectiveness of the vaccine.
Paracetamol inhibits the synthesis of prostaglandin in the hypothalamus, which then inhibits the hypothalamic heat-regulating centre, and produces antipyresis.
Paracetamol can help to reduce discomfort and pain at the site of the injection. It can also reduce the risk of fever, which can be dangerous for infants.
Yes, there is a risk that the vaccine may be less effective if paracetamol is given at an early stage to prevent fever. This is because paracetamol may interfere with the infant's immune response to the vaccine.
Ibuprofen is another antipyretic that can be used for fever reduction. However, it is important to note that ibuprofen may also reduce responses to certain antigens in vaccines.
